Publications by authors named "Angel Ferrandez Longás"

17Publications

[Not Available].

Nutr Hosp 2016 Jul 19;33(4):388. Epub 2016 Jul 19.

Unidad de Endocrinología Pediátrica. Hospital Infantil Universitario Miguel Servet. Zaragoza.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.20960/nh.388DOI Listing
July 2016

Metabolic syndrome and endothelial dysfunction in a population born small for gestational age relationship to growth and Gh therapy.

Pediatr Endocrinol Rev 2013 Mar-Apr;10(3):297-307

Andrea Prader Foundation, IACS (Instituto de Ciencias de La Salud-Institute of Health Sciences), Government of Aragon.

View Article

Download full-text PDF

Source
June 2013

Neurocognitive development of children born small for gestational age (SGA). An update.

Pediatr Endocrinol Rev 2012 Aug;9(4):716-26

Andrea Prader Foundation, IACS (Instituto de Ciencias de La Salud - Institute of Health Sciences), Government of Aragon.

View Article

Download full-text PDF

Source
August 2012

Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study.

J Clin Endocrinol Metab 2010 Nov 4;95(11):E373-83. Epub 2010 Aug 4.

Department of Endocrinology, Centre Hospitalier Universitaire de Liège, University of Liège, Liège, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2009-2556DOI Listing
November 2010

Growth and growth hormone treatment in short stature children born small for gestational age.

Pediatr Endocrinol Rev 2009 Feb;6 Suppl 3:350-7

Endocrinology Unit. University Children's Hospital "Miguel Servet", Zaragoza, Spain.

View Article

Download full-text PDF

Source
February 2009

Study of apoptosis and related proteins, CRH and hpGH in placentas of newborns small for gestational age (SGA).

Pediatr Endocrinol Rev 2009 Feb;6 Suppl 3:337-42

Molecular Genetics Lab. Uni. Hosp. Miguel Servet, Zaragoza, Spain.

View Article

Download full-text PDF

Source
February 2009

Children born small for gestational age: multidisciplinary approach.

Pediatr Endocrinol Rev 2009 Feb;6 Suppl 3:324-5

Miguel Servet Children's Hospital, Zaragoza, Spain.

View Article

Download full-text PDF

Source
February 2009

Growth hormone does not alter CYP2A6 activity in growth hormone-deficient children.

Basic Clin Pharmacol Toxicol 2008 Jan 9;102(1):45-9. Epub 2007 Oct 9.

Department of Pharmacology, Medical School, University of Zaragoza, Zaragoza, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1742-7843.2007.00139.xDOI Listing
January 2008

Lack of effect of growth hormone replacement therapy on CYP1A2 and xanthine oxidase activities in growth hormone-deficient children.

Eur J Clin Pharmacol 2006 Feb 12;62(2):123-7. Epub 2006 Jan 12.

Department of Pharmacology, Medicine School, University of Zaragoza, Domingo Miral s/n, 50009, Zaragoza, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-005-0082-yDOI Listing
February 2006

Effects of growth hormone deficiency and rhGH replacement therapy on the 6beta-hydroxycortisol/free cortisol ratio, a marker of CYP3A activity, in growth hormone-deficient children.

Eur J Clin Pharmacol 2004 Oct 7;60(8):559-64. Epub 2004 Sep 7.

Clinical Pharmacology Unit, Medicine School, University of Zaragoza, Domingo Miral s/n, 50009, Zaragoza, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-004-0806-4DOI Listing
October 2004